Francesco Autore
About
Francesco Autore is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology.
According to data from OpenAlex, Francesco Autore has authored 54 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Genetics, 23 papers in Pathology and Forensic Medicine and 21 papers in Hematology. Recurrent topics in Francesco Autore's work include Chronic Lymphocytic Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (21 papers) and Immunodeficiency and Autoimmune Disorders (15 papers). Francesco Autore is often cited by papers focused on Chronic Lymphocytic Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (21 papers) and Immunodeficiency and Autoimmune Disorders (15 papers). Francesco Autore collaborates with scholars based in Italy, United States and Japan. Francesco Autore's co-authors include Luca Laurenti, Idanna Innocenti, Federica Sorà, Simona Sica, Patrizia Chiusolo, Alessandra Ferrajoli, Elisabetta Metafuni, Paolo Strati, Eugenio Galli and Andrea Bacigalupo and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and Frontiers in Immunology.
In The Last Decade
Francesco Autore
46 papers receiving 309 citations
Peers
Francesco Autore
Cécile Tomowiak France
Mayur Narkhede United States
Valeria Fiaccadori Italy
Thérèse Aurran‐Schleinitz France
Massimo Pini Italy
Tarik Kanouni France
Haerim Chung South Korea
Sandra Bašić‐Kinda Croatia
Citations per year, relative to Francesco Autore Francesco Autore (= 1×)
peers
Cécile Tomowiak
Countries citing papers authored by Francesco Autore
Since
Specialization
Citations
This map shows the geographic impact of Francesco Autore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Autore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Autore more than expected).
Fields of papers citing papers by Francesco Autore
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Francesco Autore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Autore. The network helps show where Francesco Autore may publish in the future.
Co-authorship network of co-authors of Francesco Autore
This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Autore. A scholar is included among the top collaborators of Francesco Autore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Autore. Francesco Autore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Castillo, Jorge J., Francesco Autore, Neil L. Berinstein, et al.. (2025). Report of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors. Seminars in Hematology. 62(2). 113–119.
2.
Maccora, Daria, Michele Guerreri, Francesco Autore, et al.. (2025). The Predictive Role of Baseline 18F-FDG PET/CT Radiomics in Follicular Lymphoma on Watchful Waiting: A Preliminary Study. Diagnostics. 15(4). 432–432.
3.
D’Arena, Giovanni, Candida Vitale, Giuseppe Pietrantuono, et al.. (2024). What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study. Cancers. 16(2). 469–469.
4.
Innocenti, Idanna, et al.. (2024). Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed. Cancers. 16(11). 2011–2011.
5.
Innocenti, Idanna, Eugenio Galli, Patrizia Chiusolo, et al.. (2023). Prevention of CINV in Patients with Multiple Myeloma or Lymphoma Undergoing Hematopoietic Stem Cell Transplantation: NEPA Versus Ondansetron. a Monocentric Real-Life Experience. Blood. 142(Supplement 1). 7067–7067.
6.
Galli, Eugenio, Silvia Bellesi, Elisabetta Metafuni, et al.. (2023). Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management. European Journal Of Haematology. 112(2). 184–196.
7.
Innocenti, Idanna, Michela Tarnani, Eugenio Galli, et al.. (2023). Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience. Cancers. 15(23). 5592–5592.
8.
Autore, Francesco, Patrizia Chiusolo, Federica Sorà, et al.. (2023). Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience.. Mediterranean Journal of Hematology and Infectious Diseases. 15(1). e2023009–e2023009.
9.
Galli, Eugenio, Federica Sorà, Stefan Hohaus, et al.. (2022). Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti‐CD19 CAR‐T cells. British Journal of Haematology. 201(1). 86–94.
10.
Galli, Eugenio, Elisabetta Metafuni, Sabrina Giammarco, et al.. (2022). Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. Bone Marrow Transplantation. 57(4). 532–537.
11.
Galli, Eugenio, Federica Sorà, Sabrina Giammarco, et al.. (2022). Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia. Supportive Care in Cancer. 30(6). 4953–4959.
12.
Autore, Francesco, et al.. (2021). Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review. Journal of Clinical Medicine. 10(21). 5104–5104.
13.
Chiusolo, Patrizia, Francesco Autore, Sabrina Giammarco, et al.. (2021). IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?. Mediterranean Journal of Hematology and Infectious Diseases. 13(1). e2021062–e2021062.
14.
Autore, Francesco, Patrizia Chiusolo, Federica Sorà, et al.. (2021). Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience. Frontiers in Oncology. 11. 614721–614721.
15.
Chiusolo, Patrizia, Luca Laurenti, Idanna Innocenti, et al.. (2020). DAYS ALIVE OUTSIDE HOSPITAL AND RE-ADMISSIONS IN PATIENTS UNDERGOING ALLOGENEIC TRANSPLANTS FROM IDENTICAL SIBLINGS, UNRELATED DONORS OR HAPLOIDENTICAL DONORS “.. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020055–e2020055.
16.
Autore, Francesco, Nicola Piccirillo, Andrea Nozza, et al.. (2019). Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers. Biology of Blood and Marrow Transplantation. 25(12). 2514–2516.
17.
Autore, Francesco, Paolo Strati, Luca Laurenti, & Alessandra Ferrajoli. (2018). Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review. Haematologica. 103(6). 931–938.
18.
Laurenti, Luca, Idanna Innocenti, Francesco Autore, Simona Sica, & Dimitar G. Efremov. (2016). New developments in the management of chronic lymphocytic leukemia: role of ofatumumab. OncoTargets and Therapy. 9. 421–421.
19.
Laurenti, Luca, Francesco Autore, Idanna Innocenti, et al.. (2015). Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. Leukemia & lymphoma. 56(10). 2841–2846.
20.
Laurenti, Luca, Barbara Vannata, Idanna Innocenti, et al.. (2013). CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.. Mediterranean Journal of Hematology and Infectious Diseases. 5(1). e2013031–e2013031.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Cécile Tomowiak Breakdown of academic impact, for papers by Mayur Narkhede Breakdown of academic impact, for papers by Valeria Fiaccadori Breakdown of academic impact, for papers by Thérèse Aurran‐Schleinitz Breakdown of academic impact, for papers by Massimo Pini Breakdown of academic impact, for papers by José María Fernández‐Rañada Breakdown of academic impact, for papers by Tarik Kanouni Breakdown of academic impact, for papers by Haerim Chung Breakdown of academic impact, for papers by Sandra Bašić‐Kinda